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Abstract
Various theoretical studies have been carried out to infer relevant protein-protein interactions among
pathogens and their hosts. Such studies are generally based on preferential attachment of bacteria /
virus to their human receptor homologs. We have analyzed 17 pathogenic species mainly belonging to
bacterial and viral pathogenic classes, with the aim to identify the interacting human proteins which
are targeted by both bacteria and virus specifically. Our study reveals that the TLRs play a crucial
role between the pathogen-associated molecular patterns (PAMPs) and the damage associated molecular
patterns (DAMPS). PAMPs include bacterial lipopolysaccharides (LPs), endotoxins, bacterial flagellin,
lipoteichoic acid, peptidoglycan in bacterial organisms and nucleic acid variants associated with viral
organisms, whereas DAMPs are associated with host biomolecules that perpetuate non-infectious inflam-
matory responses. We found out the presence of SOD1 and SOD2 (superoxide dismutase) is crucial, as
it acts as an anti-oxidant and helps in eliminating oxidative stress by preventing damage from reactive
oxygen species. Hence, such strategies can be used as new therapies for anti-inflammatory diseases with
significant clinical outcomes.
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Table 1: Number of Pathogens and their Class (Bacteria/ Virus).
Sl. Pathogens Class Degree(Γ)
1 Helicobacter pylori Bacteria 1150
2 Chlamydia pneumoniae Bacteria 745
3 Borrelia Bacteria 660
4 Toxoplasma gondii Bacteria 378
5 Streptococcus Bacteria 109
6 Mycobacterium tuberculosis Bacteria 72
7 Bartonella Bacteria 56
8 Enteroviruses Virus 1025
9 Cytomegalovirus Virus 865
10 Epstein-Barr virus Virus 477
11 Herpes simplex virus Virus 404
12 Parvovirus B19 Virus 390
13 Human herpesvirus 6 Virus 386
14 Influenza A Virus 224
15 Hepatitis C virus Virus 199
16 HIV Virus 180
17 Hepatitis B virus Virus 103
1 Introduction
The interactions between pathogens (e.g. virus, bacteria, etc.) and their host (e.g. humans, plants) can
be illustrated on a single-cell level (individual encounters of pathogen and host), on a molecular level (e.g.
pathogenic protein binds to receptor on human cell), at the level of an organism (e.g. virus infects host), or
on the population level (pathogen infections affecting a human population). Investigating the host and the
pathogen protein networks in the host-pathogen interactome may allow us to better understand the crucial
intermediaries in action which aid in the functioning of the host immune system. The important interacting
proteins present in the host cell could be utilized as potential drug targets [1]. A system of interacting
elements can be examined using graph theoretical techniques.
2 Materials and Methods
We make use of centrality indices to identify the most important vertices within a graph [3], [4]. Herein,
for our undirected graph Γ, such that Γp = (Vp, Ep), the set of all nodes (protein coding genes) is denoted
by (Vp). Ep is the set of corresponding edges (interactions) between human proteins (Hp) and pathogen
organisms (Pp). The important interacting proteins in the constructed human host-pathogen bipartite graph
were listed as hubs and subsequently studied the extent of their vulnerability to the pathogenic proteins. We
have used the DisGeNET database (v 4.0) [2] and cross-referenced the pathogens that are specifically linked
with diseases associated with infectious pathogens. The linked pathogens are either directly responsible to
cause the infectious disease or are known to be found frequently in patients suffering from the disease. The
entries in the dataset are manually curated and also supported by strong experimental evidence.
Our curated dataset linked with 17 pathogenic organisms comprises of 7,423 number of associations
(edges) that interact with 2,648 unique human protein coding genes (nodes).
2.1 Network construction from Data
2.1.1 Human-Pathogen Interactome Network
We construct network based graph from the data that is experimentally validated based on physical inter-
actions between the two distinct set of proteins.
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Figure 1: The Pathogen-Host Network depicting the interactions (edges) between human and pathogenic
proteins (nodes). Herein we can see the dense cluster of pathogenic genes around important interacting
human proteins.
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Table 2: Overview of PHI Networks
Parameters Nos.(#)
Total no. of pathogens 17
No. of human proteins (Hp) 2,536
Total no. of associations interacting with pathogens 7,019
Parameter Statistics
Connected Components 13
Network Diameter 9
Network Centralization 0.264
Shortest Paths 6,856,592 (97%)
Characteristic Path Length 3.709
Average number of Neighbours 3.681
Network Heterogeneity 6.519
Multi-edge node pairs 1324
Table 3: Summary of Network Statistics of PHI Networks
2.2 Network Metrics
Biological processes can be analyzed by using a wide scale of network based approaches in which the biological
entities (e.g. genes, proteins or diseases) are represented in the form of nodes and edges which represent
the type of interaction between such entities. Key nodes that are connected to multiple number of edges
are known as hubs. A bipartite network is a graph in which edges connect a distinct set of source nodes to
another set of target nodes (i.e. nodes that do not belong to the same set of nodes). Such approaches have
been conceived theoretically and have been found useful in biomedical applications.
3 Results and Discussion
3.1 Node Degree Distribution
The node degree distribution is an indicator of the number of nodes with a degree of k. The node degree of
a particular node n is the number of interacting edges linked to n, in undirected networks.
Figure 2: Node Degree Distribution depicts the scale-free network topology of our pathogen-host network.
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3.2 Topological Coefficient
Topological coefficient T (n) of a node n with kn neighbors is defined as the number of neighbors shared
between a pair of nodes, kn and km, divided by the number of neighbors of node kn:
T (n) =
avg(J(n,m))
kn
(1)
where the value of J(n,m) is the number of neighbors shared between the nodes n and m, plus one if
there is a direct link between n and m. It gives a relative measure of a node that shares it’s neighbors with
other nodes and is defined for all nodes m that share at least one neighbor with n.
Figure 3: Topological Coefficient is used to estimate the tendency of the nodes to have shared neighbors in
the pathogen-host network.
3.3 Betweenness Centrality
Betweenness centrality of a node v is the sum of the fraction of all-pairs shortest paths that pass through v.
CB(v) =
∑
s,t∈V
σ(s, t|v)
σ(s, t)
(2)
where V is the set of nodes, σ(s, t) is the number of shortest (s, t) paths, and σ(s, t|v) is the number
of those paths passing through some node v other than s, t [5]. Hubs that tend to have high betwenness
centrality are expected to lie in between many shortest paths and exhibit that even low-degree nodes with
high betweeness may reveal a modular network structure [6].
Figure 4: Betweenness Centrality
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(a) TLR1 (b) TLR2 (c) TLR3 (d) TLR4 (e) TLR7 (f) TLR8
Figure 5: The blue-colored regions depict Leucine Rich Repeat regions (LRRs) of Toll-like receptors. Based
on the number of interactions, Toll-like receptors viz. TLR1, TLR2 and TLR4 were found to be more
susceptible to bacterial proteins, whereas TLR3, TLR7 and TLR8 were more preferential to viral proteins.
TLRs such as TLR5 and TLR6 were also found to be slightly more susceptible towards bacterial pathogenic
proteins.
Gene Degree Topol. Coeff. Betw. Centrality. Protein Molecular Function
SOD2 41 0.16262985 0.00602848 Superoxide dismutase [Mn], mitochondrial Oxidoreductase
PTGS2 40 0.18507808 0.00330486 Prostaglandin G/H synthase 2 Dioxygenase, Oxidoreductase, Peroxidase
TNF 36 0.16444268 0.00484062 Tumor necrosis factor Cytokine activity
TP53 33 0.1629871 0.00404872 Cellular tumor antigen p53 Apoptosis, DNA-binding, Host-virus interaction
PLAU 31 0.19851805 0.0028075 Urokinase-type plasminogen activator Hydrolase, Protease, Serine protease
NOS2 27 0.1847816 0.00412495 Nitric oxide synthase, inducible Calmodulin-binding, Oxidoreductase
PLAT 26 0.2231064 0.00163375 Tissue-type plasminogen activator Hydrolase, Protease, Serine protease
IL6 24 0.19647329 0.00346007 Interleukin-6 Cytokine, Growth factor
ACE 22 0.20865038 0.00227199 Angiotensin-converting enzyme Carboxypeptidase, Hydrolase, Protease
IL1B 22 0.19851805 0.0028075 Interleukin-1 beta Cytokine, Pyrogen, Inflammatory response
IFNG 22 0.19776016 0.00359721 Interferon gamma Antiviral defense, Growth regulation
SOD1 21 0.1748717 0.0034557 Superoxide dismutase [Cu-Zn], soluble Antioxidant, Oxidoreductase
STAT3 20 0.19647329 0.00346007 Signal transducer and activator of transcription 3 Activator, DNA-binding, Host-virus interaction
MTHFR 19 0.19866054 0.00260592 Methylenetetrahydrofolate reductase Allosteric enzyme, Oxidoreductase
CCL2 19 0.18357301 0.003561 C-C motif chemokine 2 Cytokine , Chemotaxis, Inflammatory response
Table 4: Common Sub-group of Human Proteins during the cross-talk of pathogen and damage associated
molecular patterns.
Figure 6: Toll-like receptor (TLR) Signaling Pathway are membrane-bound host (human) proteins that
respond to Gram-positive and Gram-negative bacteria. They induce pro-inflammatory cytokines and are
responsible for producing innate immune responses.
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3.4 Pathogen-associated molecular patterns
The immune responses in response to the pathogen-associated molecular patterns (PAMPs) help protecting
the host from infection. In our case, we found that the leucine rich-repeat (LRR) regions of Toll-like
receptors initiate / perpetuate a cascade of mechanisms within the host, once they are able to detect the
lipopolysaccharides(LPSs) and other glycoconjugates found predominantly in bacteria and other nucleic acid
derivatives in viruses. In our findings, we found that the TLRs frequently interact with the common sub-
group of Human proteins that have higher values of Betweenness Centrality as depicted in Table 4. It has
also been reported that the TLRs have a role in stimulating TNF and IL6 production [8].
3.5 Damage-associated molecular pattern
Release of intra-cellular material leads to interfere with the membrane integrity and the ability to stimulate
inflammatory response. DAMPs also have been found to play a crucial role to stimulate pattern-recognition
receptors (PPRs) that comprise of Toll-likereceptors (TLRs) and leucine-rich repeat containing molecules.
Thereafter, alarmins such as interleukins and interferons that are stored in cells and released upon cell lysis,
are responsible for inflammatory responses.
Gene Protein Uniprot ID No. of Pathogens GO Molecular Function
Bacteria Virus
TLR1 Toll-like receptor 1 Q15399 30 4 TLR2 binding, Transmembrane signaling receptor activity
TLR2 Toll-like receptor 2 O60603 83 18 Lipopolysaccharide receptor activity, Signaling PRR activity
TLR3 Toll-like receptor 3 O15455 8 29 ds RNA binding, Transmembrane signaling receptor activity
TLR4 Toll-like receptor 4 O00206 63 22 Lipopolysaccharide and Transmembrane signaling receptor activity
TLR5 Toll-like receptor 5 O60602 13 5 Interleukin-1 receptor binding
TLR6 Toll-like receptor 6 Q9Y2C9 19 3 Identical protein binding, lipopeptide binding, TLR2 binding
TLR7 Toll-like receptor 7 Q9NYK1 4 16 ds/ss RNA binding, siRNA binding
TLR8 Toll-like receptor 8 Q9NR97 6 13 ds/ss DNA binding, DNA binding, signaling receptor activity
TLR9 Toll-like receptor 9 Q9NR96 20 20 interleukin-1 receptor binding, siRNA binding,
TLR10 Toll-like receptor 10 Q9BXR5 2 2 Identical protein binding, Transmembrane signaling receptor activity
Table 5: Overview of Toll-like receptors (TLRs) and their interactions with bacterial and viral proteins. The
number depicted above signifies the number of interactions with bacterial/viral pathogenic proteins.
4 Conclusions
The predominant proteins/ protein coding genes which were found to indicate extensive cross-talk among
themselves are described as follows:
The Superoxide dismutase [Mn], mitochondrial (SOD2) gene encodes an enzyme (Mn dependent) in hu-
mans which converts superoxide anion free radicals produced within cells to hydrogen peroxide and diatomic
oxygen, thereby inhibiting cellular oxidative stress leading to apoptosis. As a result this gene eliminates
the production of mitochondrial reactive oxygen species (ROS) and protects from programmed cell death.
Interestingly, this gene has also been found to interact with p53 and NFκB1 gene [9] which have earlier been
found vulnerable to multiple pathogens.
The Prostaglandin-endoperoxide synthase 2 (PTGS2) gene encodes an enzyme which is responsible for the
conversion of arachidonic acid to prostaglandin H2, that acts as a precursor of prostacyclin, and expressed
in inflammation [10]. The PTGS2 gene is generally unexpressed under typical conditions but the levels
are up-regulated during inflammation. The present line of treatment lies in selective inhibition of PTGS1
(COX-1) and PTGS2 (COX-2) by the use of Non-steroidal anti-inflammatory drugs (NSAIDs) that suppress
prostaglandin synthesis [11].
The Tumor necrosis factor (TNFα) is a cytokine that is induced mainly by activated macrophages and
other cell types as well [12]. It’s main role lies in the regulation of immune cells and functionally it is able to
induce apoptosis [13]. Furthermore, it is also interesting to note that TNFα has also been found to interact
with NFκB1 and SOD [Mn] as well and large amounts of TNF are released in response to lipopolysaccharide
products upon stimulus in case of inflammation [14].
The cellular tumor antigen or phosphoprotein 53 (TP53) protein is a tumor suppressor protein and it
negatively regulates cell division either by stimulation of BAX and FAS antigen expression or by repressing
Bcl-2 expression. The main function of TP53 in many tumor types is to induce growth arrest depending on
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the physiological circumstances [15]. Further, it also acts as a trans-activator [16]. As such, TP53 has an
important role in preserving stability of the genome by inhibiting mutagens in the genome [17].
The Plasminogen Activator, Urokinase (PLAU) enzyme encoded by PLAU gene is a serine protease
enzyme. It is primarily involved in the cleavage of zymogen plasminogen to form active form of plasmin [18].
The production of plasmin results in the thrombolysis of the extracellular matrix of the fibrin lattice in blood
clots, which in turn facilitates tissue infiltration leading to metastasis [19].
The Nitric oxide synthase, inducible is an enzyme encoded by NOS2 gene. Nitric oxide is a free radical re-
active species acting as a mediator in anti-microbial activities. It is generally induced by lipopolysacccharides
and cytokines in inflammation [20].
Tissue-type plasminogen activator (PLAT) is a protein involved in the fibrinolysis of blood clots and
plays a significant role in cell migration and in various pathological conditions [21].
Interleukin-6 (IL6) is a pro-inflammatory cytokine encoded by the IL6 gene secreted by macrophages
in response to pathogens. Interleukins are present on the cell surface and plays a significant role in B-cell
differentiation into various immune cells such as lymphocytes and monocytes [22].
Angiotensin-converting enzyme is an enzyme encoded by the ACE gene that converts Angiotensin I to
Angiotensin II leading to vasoconstriction of blood vessels. It mainly inactivates bradykinin which functions
as an inflammatory mediator [23]
Interleukin-1 Beta (IL1B) may facilitate as a pro-inflammatory cytokine. It mainly induces synthesis of
prostaglandins and activates cytokine production accompanied by T-cell / B-cell activation and antibody
production [24].
Interferon gamma (IFNG) belongs to a class of cytokine that is vital for annate and adaptive immunity
against pathogens under type-II class of interferons encoded by the IFNG gene [25].
Superoxide dismutase [Cu-Zn] also known as Superoxide dismutase 1 is an enzyme encoded by SOD1
gene that binds to [Cu-Zn] ions and eliminates free radicals produced within the cells. During oxidative
stress, SOD1 limits the detrimental effects of reactive oxygen species (ROS) thereby regulating programmed
cell death during apoptosis [26].
Signal Transducer and activator of transcription 3 (STAT3) is a transcription factor encoded by STAT3
gene. It plays a major role in regulating cell-growth and apoptosis after getting phosphorylated by Mitogen-
activated protein kinases (MAPK) / receptor associated Janus kinases (JAK) and ligands such as interferons
and interleukins (IL5 and IL6) [27].
Methylene tetrahydrofolate reductase (MTHFR) is an enzyme critical in the rate-limiting step in the
methyl cycle that is encoded by the MTHFR gene. Methylenetetrahydrofolate reductase deficiency (MTH-
FRD) is found to be associated with a wide range of autosomal recessive disorders that includes homocys-
teinuria, homocysteinemia, psychiatric disorders and other neurodegenerative diseases [28].
C-C motif chemokine ligand 2 (CCL2) activates the C-C chemokine receptor (CCR2) by acting as a ligand
and signals monocytes, dendritic cells and memory T-cells at the inflammation site during infection [29]. It
is present in the plasma membrane of endothelial cells and is mainly induced by macrophages and platelet
derived growth factor [30].
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